tiprankstipranks
Trending News
More News >
Hims & Hers Health (HIMS)
NYSE:HIMS
US Market
Advertisement

Hims & Hers Health (HIMS) Earnings Dates, Call Summary & Reports

Compare
8,112 Followers

Earnings Data

Report Date
Mar 02, 2026
TBA (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.07
Last Year’s EPS
0.11
Same Quarter Last Year
Based on 11 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 03, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presents a strong performance with significant revenue growth, strategic partnerships, and international expansion. However, there are challenges in gross margins and increased G&A costs. The company's strategy and future outlook remain optimistic.
Company Guidance
During the Hims & Hers Third Quarter 2025 Earnings Call, the company provided strong guidance for future growth, highlighting a year-over-year revenue increase of nearly 50% to almost $600 million and adjusted EBITDA margins above 13%. The company anticipates fourth-quarter revenue between $605 million and $625 million, with a full-year projection of $2.335 billion to $2.355 billion, marking a 58% to 59% increase from the previous year. Adjusted EBITDA for the year is expected to range from $307 million to $317 million, reflecting a 13% margin at the midpoint. Hims & Hers anticipates substantial growth in its subscriber base, which increased by more than 30,000 sequentially, with a year-over-year growth rate of 20%. Looking ahead, the company aims for over $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030, with plans to expand internationally and enhance its offerings in weight loss, hormone health, and diagnostics.
Significant Revenue Growth
Revenue grew 49% year-over-year to nearly $600 million in Q3, with expectations of $2.335 billion to $2.355 billion for the full year, reflecting a 58% to 59% increase.
Subscriber Base Expansion
Subscriber base increased by more than 30,000 sequentially, reflecting a 20% year-over-year growth rate.
Strategic Partnerships and Investments
Active discussions with Novo Nordisk for Wegovy and strategic investment in GRAIL highlight a focus on expanding consumer options and multi-cancer early detection.
Innovative Product Launches
Launch of low testosterone and menopause offerings, with plans for whole body lab testing and longevity specialty to drive future growth.
International Expansion
Expansion into international markets, including upcoming launches in Canada, leveraging the acquisition of Zava Global.

Hims & Hers Health (HIMS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

HIMS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 02, 2026
2025 (Q4)
0.07 / -
0.11
Nov 03, 2025
2025 (Q3)
0.09 / 0.06
0.32-81.25% (-0.26)
Aug 04, 2025
2025 (Q2)
0.15 / 0.17
0.06183.33% (+0.11)
May 05, 2025
2025 (Q1)
0.12 / 0.20
0.05300.00% (+0.15)
Feb 24, 2025
2024 (Q4)
0.11 / 0.11
0.011000.00% (+0.10)
Nov 04, 2024
2024 (Q3)
0.11 / 0.32
-0.04900.00% (+0.36)
Aug 05, 2024
2024 (Q2)
0.04 / 0.06
-0.03300.00% (+0.09)
May 06, 2024
2024 (Q1)
0.01 / 0.05
-0.05200.00% (+0.10)
Feb 26, 2024
2023 (Q4)
-0.02 / 0.01
-0.05120.00% (+0.06)
Nov 06, 2023
2023 (Q3)
-0.04 / -0.04
-0.0955.56% (+0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

HIMS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 03, 2025
$44.39$42.79-3.60%
Aug 04, 2025
$63.35$55.52-12.36%
May 05, 2025
$41.88$49.47+18.12%
Feb 24, 2025
$51.31$39.86-22.32%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Hims & Hers Health (HIMS) report earnings?
Hims & Hers Health (HIMS) is schdueled to report earning on Mar 02, 2026, TBA (Confirmed).
    What is Hims & Hers Health (HIMS) earnings time?
    Hims & Hers Health (HIMS) earnings time is at Mar 02, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is HIMS EPS forecast?
          HIMS EPS forecast for the fiscal quarter 2025 (Q4) is 0.07.

            Hims & Hers Health (HIMS) Earnings News

            Hims & Hers Health (HIMS) to Report Q3 Earnings on November 3. Option Traders Expect a 14.94% Move
            Premium
            Market News
            Hims & Hers Health (HIMS) to Report Q3 Earnings on November 3. Option Traders Expect a 14.94% Move
            4d ago
            Hims & Hers Health (HIMS) Is About to Report Q2 Earnings. Here’s What to Expect
            Premium
            Market News
            Hims & Hers Health (HIMS) Is About to Report Q2 Earnings. Here’s What to Expect
            3M ago
            HIMS Earnings: Hims & Hers Skyrockets on Q4 Beat
            Premium
            Market News
            HIMS Earnings: Hims & Hers Skyrockets on Q4 Beat
            2y ago
            Hims & Hers (NYSE:HIMS) Soars on Healthy Q3 Performance
            Premium
            Market News
            Hims & Hers (NYSE:HIMS) Soars on Healthy Q3 Performance
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis